Key facts
- This page summarizes Dara Wright's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Sep 2022, 14:12.
Dara Wright - 01 Sep 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- BIO
- Reported as of
- 01 Sep 2022
- Net transaction value
- -$68,561
- SEC form
- 4
- Accepted by SEC
- 06 Sep 2022, 14:12:11 UTC
- Prior SEC filing
- 17 Dec 2021
- Next SEC filing
- 07 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dara Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Dara Wright filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 06 Sep 2022.
Change
- Previous filing in this sequence was filed on 17 Dec 2021.
- Current net transaction value: -$68,561.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIO
transaction
Bio-Rad A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +405
- Change %
- +44%
- Price
- $0.000000
- Shares after
- 1,318
- Date
- 01 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F2
BIO
transaction
Bio-Rad A Common Stock
Tax liability
- Transaction value
- $68,561
- Shares
- -141
- Change %
- -11%
- Price
- $486.25
- Shares after
- 1,177
- Date
- 01 Sep 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +2,082
- Change %
- Price
- $0.000000
- Shares after
- 2,082
- Date
- 01 Sep 2022
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 2,082
- Exercise price
- $0.000000
- Footnotes
- F3, F4
BIO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -405
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 1,216
- Date
- 01 Sep 2022
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 405
- Exercise price
- $0.000000
- Footnotes
- F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
Footnote F2
Includes 20.8996 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2022.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
Footnote F4
The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Footnote F5
On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.